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Abstract: 33 
      Encapsulation of krill oil (KO), a rich source of eicosapentanoic (EPA) and 34 
docosahexanoic acid (DHA) was carried out in chitosan-TPP (tripolyphosphate) 35 
nanoparticles using a newly developed two-step process (i.e, formation of emulsion and later 36 
electrostatic interaction of chitosan with TPP). The encapsulation of KO in chitosan 37 
nanoparticles (CSNPs) was confirmed by using Fourier transform infrared spectroscopy 38 
(FTIR), X-ray diffraction (XRD) and Thermo gravimetric analysis (TGA) techniques. 39 
Loading capacity (LC) and encapsulation efficiency (EE) of the obtained particles were about 40 
9 – 25 and 33 – 59 % respectively, when the initial KO content was in the ratio of 0.25 – 1.25 41 
g/g of Chitosan. Bulk KO showed less protection to oxidation and showed more formation of 42 
hydroperoxides during first week as noted by FTIR. However, KO loaded CSNPs showed 43 
better prevention of KO towards oxidation with less hydroperoxide formation even after two 44 
weeks of storage at elevated temperature (45 
o
C). The obtained KO-loaded CSNPs were 45 
irregular in shape with an average particle diameter of < 130 nm as observed by SEM. The 46 
results obtained confirmed the suitability of the emulsion and later electrostatic interaction of 47 
CS with TPP for the formation of KO loaded CSNPs with greater EE & LC, which will 48 
enhance their usage in the Food and Pharmaceutical industries. 49 
 50 
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1. Introduction 53 
Antarctic Krill (Euphausia superba) has recently emerged as a potential and rich alternative 54 
source of long chain omega-3 polyunsaturated fatty acids (LC ω-3 PUFAs) besides the algal and 55 
fish oils to be substituted as a dietary supplements. Krill oil (KO) contains long chain omega-3 56 
polyunsaturated fatty acids (LC ω-3 PUFAs), namely eicosapentaenoic acid (EPA, 20:5) and 57 
docosahexaenoic acid (DHA, 22:6) (Grandois, Marchioni, Minjie Zhao, Ennahar, & Bindler, 58 
2009). The fatty acids in fish oil are stored as triglyceride, whereas in KO approximately 30 – 65 59 
% of the fatty acids are predominantly incorporated into phospholipids (Schuchardt et al., 2011; 60 
Tou, Jaczynski, & Chen, 2008). The particular and unique amphiphilic structural arrangement of 61 
phospholipids provides KO with a much better bioavailability (Schuchardt et al., 2011). 62 
Moreover, KO contains naturally occurring powerful antioxidants mainly astaxanthin (Deutsch, 63 
2007; Tou et al., 2008). Various researchers recommend use of KO to prevent chronic disorders 64 
like cardiovascular diseases, endocannabinoide, poor infant development, non-alcoholic fatty 65 
liver disease, premenstrual syndrome, inflammation and certain cancers. This preventive effect 66 
was credited to the synergistic action between KO constituents LC ω-3 PUFAs, phospholipids 67 
and astaxanthin (Deutsch, 2007; Sampalis et al., 2003; Tur, Bibiloni, Sureda, & Pons, 2012). 68 
However, its limited solubility in water and rapid instability to oxidation had made it difficult to 69 
achieve these benefits (Bustos, Romo, Yáñez, Díaz, & Romo, 2003).  70 
To avoid limited solubility (Dispersibility in aqueous media), and the oxidative instability of 71 
lipophilic compounds like KO, various researchers encapsulate them in protein and carbohydrate 72 
based matrices (Ilyasoglu & El, 2014; Zimet & Livney, 2009). In addition to the above 73 
mentioned benefits, nanoencapsulation of lipophilic compounds also increased their 74 
bioavailability (Fathi, Mozafari, & Mohebbi, 2012). However, protein and polysaccharides that 75 
have been used widely to encapsulate lipophilic compounds play a key role in attaining the 76 
benefits (Chen & Subirade, 2005; Wang et al., 2006). For example, Majeed et al, prepared clove 77 
oil loaded nanoemulsions using modified starch and Tween 80 based surfactants and attained 78 
controlled release of oil from starch based nanoemulsions. However, Tween 80 adsorbed onto 79 
the droplet and failed to provide the desired release of oil (Majeed et al., 2016). 80 
Chitosan (CS), a cationic polysaccharide that has been used widely for encapsulation and 81 
delivery of lipophilic compounds due to its biodegradability (enzymatically degraded 82 
(Lysozyme) into fragments suitable for renal clearance), biocompatibility, non-antigenicity and 83 
low toxicity (Malafaya, Silva, & Reis, 2007). Recently, researchers used a two-step emulsion and 84 
ionic-gelation method to produce CS-TPP nanoparticles due to its simplicity and non-toxicity for 85 
targeted delivery of bioactives (Malafaya et al., 2007; Yang et al., 2011). In the two step, 86 
emulsion ionic-gelation procedure the latter involves electrostatic interaction between cationic 87 
groups of CS and anionic groups of TPP (Calvo, Remuñán-López, Vila-Jato, & Alonso, 1997; 88 
Kawashima et al., 1985; Yang et al., 2011). The electrostatic interaction between cationic groups 89 
of CS and anionic groups of TPP occurred by inter and intramolecular bonds (Calvo et al., 1997; 90 
Kawashima et al., 1985; Yang et al., 2011). Ionic-gelation based CSNPs have been used widely 91 
for the encapsulation, and targeted delivery of proteins (Kawashima et al., 1985; Xu & Du, 92 
2003), essential oils (Hosseini, Zandi, Rezaei, & Farahmandghavi, 2013; Keawchaoon & 93 
Yoksan, 2011), drugs (Wang et al., 2006; Wu, Yang, Wang, Hu, & Fu, 2005), vitamins and 94 
nutrients (Chen & Subirade, 2005; Yoksan, Jirawutthiwongchai, & Arpo, 2010). Keawchaoon 95 
and Yoksan revealed successful encapsulation of carvacrol in CS-TPP particles with extended 96 
shelf life and well retained functional properties (Keawchaoon & Yoksan, 2011). Similarly, 97 
Hosseini et al, prepared oregano oil loaded CS-TPP nanoparticles by an additional step of oil-in-98 
water emulsification prior to solidification of these droplets by CS & TPP (Hosseini et al., 2013). 99 
They confirmed regularly distributed, spherical shaped particles having size 40 – 80 nm with 100 
slow release characteristics. They reported more than 80 % release of oregano oil that was 101 
attributed to greater surface volume ratio due to smaller particle size. On the other hand, nano-102 
capsules due to larger size reduced the surface volume ratio and ultimately influence the access 103 
of digestive enzyme, dispersibility of their products and finally influenced the efficacy of 104 
delivery system (Kim, Diab, Joubert, Canilho, & Pasc, 2016; Majeed et al., 2016).   However, 105 
loading of KO having a distinctive chemical structure of LC ω-3 PUFAs into CSNPs at a nano-106 
level size has not been elucidated. Therefore, the current study focuses on the fabrication, 107 
characterization and oxidative stability of KO loaded in CSNPs by two step process: oil-in-water 108 
emulsification, and ionic gelation (CS & TPP).   109 
2 Materials and methods 110 
2.1  Materials 111 
Antarctic krill oil contained ~40 % total phospholipid, ~28 – 30 % total omega-3 fatty acids 112 
and ≤ 200 mg/kg astaxanthin as stated by the manufacturer (Hutai Biopharm Inc. (Sichuan, 113 
China). Partially deacetylated chitosan (CS; degree of deacetylation of 91.5 %), with average 114 
molecular weight of 100 kDa derived from crab shells was obtained from Golden-Shell 115 
Biochemical Co., Ltd. (Hangzhou, China). CS is a weak polyelectrolyte with a pKa value around 116 
6.5, which is positively charged in acidic conditions (Fan, Yan, Xu, & Ni, 2012). Tween 80, 117 
glacial acetic acid, Sodium tripolyphosphate (TPP) and all other chemicals used were of 118 
analytical grade, purchased from Sinopharm Chemical Reagent Co., Ltd., China. Double distilled 119 
water was used throughout this study. 120 
2.2 Preparation of KO-loaded CSNPs 121 
KO-loaded CSNPs were prepared using a modified version of the method described by 122 
(Calvo et al., 1997) and (Hosseini et al., 2013). A schematic illustration representing the CSNPs 123 
preparation procedure is shown in Fig. 1. Briefly, CS solution 1.5 % (w/v) was prepared by 124 
agitating CS in an aqueous acetic acid solution 1 % (v/v) at ambient temperature (25 – 28 oC) for 125 
24 h. The CS solution was centrifuged at 8000 rpm for 20 min, the supernatant was filtered 126 
through a 0.8 µm pore size syringe filter. Tween 80 (0.5g, hydrophilic-lipophilic balance = 15) 127 
was added as a surfactant to the CS solution (40 mL) and the mixture was stirred at 45 
o
C for 2 h 128 
to obtain a homogeneous solution. KO was gradually dropped into the aqueous CS solution (40 129 
mL) and the system was homogenized using an Ultra-Turrax (T25, Ika-Werke, Staufen, 130 
Germany) at a speed of 13,000 rpm for 1 min and 16,500 for 2 min. The solution was positioned 131 
in an ice-bath to prevent heating. The content of KO was varied (0, 0.15, 0.30, 0.45, 0.60 and 132 
0.75 g) to obtain different weight ratios of CS to KO (1:0, 1:0.25, 1:0.50, 1:0.75, 1:1.00 and 133 
1:1.25 respectively). Subsequently, TPP solution (0.5 % v/v, 40mL) was then added drop wise 134 
into the o/w emulsion under continuous stirring and was agitated for 40 min. The particles 135 
formed were collected by centrifugation at 10,000 × g for 30 min at 20 
o
C and washed several 136 
times with water to remove or wash off excessive KO. Eventually, the wet particles were 137 
dispersed in 25 mL water by ultrasonication to produce a homogeneous suspension. 138 
Ultrasonication was performed using a (Jy98-IIIDN, 20 kHz, Ningbi Scientz Biotechnology Co., 139 
Ltd., Ningbo, China) sonicator for 2 min in an ice bath. The suspensions were immediately 140 
freeze-dried at – 35 oC for 72 h and were stored in dry conditions at 25 oC. 141 
2.3 Characterization of KO-loaded CSNPs 142 
2.3.1 Z-average diameter and ζ-potential measurements  143 
      The z-average diameter and the uniformity of particles in dispersion (particle size 144 
distribution) that is being measured as polydispersity index (PDI) for KO-loaded CSNPs were 145 
investigated by dynamic light scattering (DLS) using the Zetasizer Nano ZS
® 
(Malvern 146 
Instruments, Worcestershire, U.K.). To avoid multiple scattering effects, the nanoparticles were 147 
diluted 100-fold with purified water, placed in a cuvette and agitated well prior to measurements. 148 
Refractive indices of 1.45 for KO and 1.330 for water were used. ζ-potential was determined by 149 
Laser Doppler Velocimetry using the Zetasizer Nano ZS
®
 at a scattering angle of 173° at 25 °C. 150 
The diluted nanoparticles were placed in a folded capillary electrophoresis cell with count rate 151 
between 100 and 300 Kcps as described by Zainol et al. (Zainol et al., 2012). All the tests were 152 
performed in triplicate.  153 
2.3.2 Morphology of KO-loaded CSNPs 154 
      The morphological characterization of the nanoparticles was done using SEM (Hitachi S- 155 
4800, Japan) at an accelerating voltage 2 kV. The powders were sprinkled onto double-backed 156 
cellophane tape attached to an aluminium stub before coating with gold-palladium in an argon 157 
atmosphere.  158 
2.3.3 Characterization using FTIR, TGA and XRD 159 
      The infrared spectra of all samples were obtained using a Thermo Fisher Scientific Inc., 160 
Nicolet iS10, FTIR spectrometer with KBr accessory. This instrument was operated with Nicolet 161 
OMNIC software (Version 8.2). For KO spectral acquisition, the liquid sample (≈ 2 µL) was 162 
deposited on a KBr disk. The spectra were obtained using 16 scans at a resolution of 4 cm
-1
 over 163 
the frequency range of 4000 – 400 cm-1. Before running each sample a background spectrum was 164 
obtained in air.  165 
Contact angle was used to determine the interaction between KO and nanoparticles with sessile 166 
drop method. Briefly, KO (3 μL) was carefully dropped with a dosing rate of 0.5 μL/s onto the 167 
slides (20 mm × 50 mm × 1 mm) using 2 mL micrometer syringe (KDL Corp., Shanghai, China). 168 
The measurements were carried out in open air with relative humidity (30%) and at a room 169 
temperature of 25 °C. Both left and right contact angles expressed in degrees were automatically 170 
calculated from the digitalized image software belonging to the equipment (DataPhysics 171 
Instruments GmbH, OCA15EC, Germany). Measurements were taken in triplicate of each 172 
sample. 173 
      TGA was performed using a TGA/DSC 1 STARe (Mettler-Toledo, Switzerland) 25 – 600 oC 174 
with a heating rate of 10 
o
C/min under nitrogen atmosphere. Each freeze-dried sample 6 – 10 mg 175 
was placed in the TGA furnace. The derivative thermogravimetric curves (DTG) and the first 176 
derivative of TG curves were calculated.  177 
      XRD patterns of packing materials were assessed by X-ray diffraction using a (Bruker AXS 178 
D8, Germany) diffractometer. The operation conditions were 40 kV and 40 mA with Cu Kα 179 
radiaton (λ = 1.5406 Å). Samples were scanned in the 2θ range of 5o – 50o at a speed of 0.03o per 180 
second. 181 
2.4 Determination of loading capacity (LC) and encapsulation efficiency (EE) 182 
      The content of KO-loaded CSNPs was determined by TGA/DTG. Freeze dried CSNPs and 183 
KO-loaded CSNPs were placed in TGA furnace at 25 – 600 oC with a heating rate of 10 oC/min 184 
under nitrogen atmosphere and the weight loss percentage, obtained from TGA thermograms 185 
was used to determine the content of KO-loaded CSNPs. The loading capacity of KO (g/100g of 186 
sample) and encapsulation efficiency of KO (g/100g of sample) were thus calculated from eqs. 187 
(1) and (2) respectively.(Yoksan et al., 2010) 188 
LC (%) = 
wight of loaded KO
Weight of sample
× 100  (1) 189 
EE (%) = 
wight of loaded KO
Weight of initial KO
× 100  (2) 190 
2.5 Storage conditions 191 
      For the lipid oxidation experiments, five grams of bulk oil and freeze-dried KO-loaded 192 
CSNPs were placed in 20 ml loosely capped amber glass bottles. Samples were stored at 45 
o
C 193 
for 4 weeks. The extent of lipid oxidation was investigated in terms of lipid hydroperoxide. All 194 
the experiments were carried out in duplicate.  195 
2.5.1 Determination of lipid oxidation 196 
In this study, lipid hydroperoxides, the primary oxidation products was monitored by FTIR 197 
(Guillén & Cabo, 1999, 2002). Each band frequency was obtained automatically from the 198 
instrument software command “find peaks” with an adequate threshold value near 85 %. The 199 
functional group vibration mode of each band was made by comparison with software spectral 200 
library as well as with literature data and similar experimental conditions of FTIR was applied 201 
for sample acquisition as utilised to confirm the loading of KO in CSNPs (See section 2.3.3). 202 
3 Results and discussion 203 
3.1 Shape, size and surface charge of KO-loaded CSNPs 204 
KO-loaded CSNPs were prepared through the formation of oil droplets (including KO) and 205 
droplet solidification. The KO droplet formation in CS solution was achieved using the O/W 206 
emulsion technique. The solidification of each droplet was extended by ionic cross-linking of 207 
ammonium groups of CS molecules surrounding the KO droplet and phosphate groups of TPP. 208 
The surface morphology of CSNPs and KO-loaded CSNPs were observed by SEM. Fig. 2 209 
(a, b) shows the CSNPs size varied between 100 – 300 nm that correlates with the findings of 210 
Yoskan (Yoksan et al., 2010). For KO-loaded CSNPs, the aggregations were also seemed that 211 
might be due to remaining KO around the particles with an average range of 80 – 130 nm (Fig. 212 
2-c, d).   213 
The z-average diameter and PDI of CSNPs and KO-loaded CSNPs were examined by 214 
dynamic light scattering (DLS). Fig. 3 shows that the z-average diameter and PDI of CS particles 215 
were about ~252 nm and 0.199, respectively. The z-average diameter of KO-loaded CSNPs were 216 
in the range of 229.5 – 182.4 nm. With increasing ratio of KO, the z-average diameter decreased 217 
(Table 1). The possible reason behind this reduction in particle size might be the coemulsifying 218 
properties of the oil constituents in the presence of surfactant that reduces the interfacial tension 219 
as various researchers reported this phenomenon for essential oil loaded nanoemulsions (Majeed, 220 
Antoniou, & Fang, 2014; Terjung, Löffler, Gibis, Hinrichs, & Weiss, 2012). However, the 221 
agglomeration and/or swelling of KO-loaded CSNPs in water were lower than those of CS 222 
particles. The obvious difference in the agglomeration of two nanoparticulate systems is the 223 
formation mechanism. The CS particles are formed by the electrostatic interaction of CS and 224 
TPP and their size will depend on how the molecules were mixed together. On the other hand, 225 
KO-loaded CSNPs are formed by the adsorption of CS onto the KO droplets. The lower 226 
agglomeration in KO-loaded CSNPs might be due to hydrophobic KO molecules that forced it to 227 
entrap inside (Keawchaoon & Yoksan, 2011; Yoksan et al., 2010). The interesting fact about KO 228 
is that it possesses a large proportion of marine phospholipids (about 40 %) bonding with LC ω-3 229 
PUFAs like EPA and DHA (Zhu, Zhuang, Luan, Sun, & Cao, 2015). Similarly, Shen and Lu et 230 
al. reported small z-average diameter of nanoparticles that can be credited to phospholipids in 231 
KO, having substantial inherent emulsifying power (Lu, Nielsen, Baron, Jensen, & Jacobsen, 232 
2012; Shen, Bhail, Sanguansri, & Augustin, 2014). 233 
In addition, ζ-potential of CSNPs gave a positive charge of + 37.7 mV as shown in Fig. 3. 234 
The positive surface charge arises due to ammonium groups of CS. With loading of KO, the ζ-235 
potential was decreased to + 26.6 mV. This reflects the CSNPs surface with increasing KO 236 
content. The reduction in ζ-potential value was related to the number of TPP to CS charge groups 237 
as evident by the findings of (Antoniou et al., 2015). However, this reduction might be due to 238 
shielding effect of protonated –NH2 group by KO on CSNPs. Several studies have reported that 239 
ζ-potential values of CSNPs was reduced when drugs, i.e., ascorbic acid (Jang & Lee, 2008) and 240 
eugenol were (Woranuch & Yoksan, 2013) incorporated. This demonstrated that ζ-potential 241 
value influenced reciprocally with increased drug content.  242 
3.2 Characterization of KO-loaded CSNPs  243 
CSNPs loaded with KO were characterized by Fourier Transform Infrared spectroscopy 244 
(FTIR). The results confirmed the presence of KO with characteristic peaks at 3416 cm
-1
 (OH), 245 
3012 cm
-1
 (=C–H stretching), 3000 – 2800 cm-1 (C–H stretching), 1740 cm-1 (C=O stretching 246 
band), 1465 cm
-1
 (–CH2– bending), 1379 cm
-1
 (–CH3 bending), 1091 cm
-1 
(CO stretching), 971 247 
cm
-1 
(C=C stretching band) as shown in Fig. 4a. 248 
However, CSNPs showed characteristics bands at 3450 cm
-1
 (OH), 2927 cm
-1
 (CH 249 
stretching), 1640 cm
-1
 (amide I), 1543 cm
-1
 (amide II), 1155 cm
-1
 (P=O), 1097 cm
-1
 (COC) and 250 
891 cm
-1
 (pyranose ring) that suggests the complex formation between CS and TPP as a result of 251 
electrostatic interaction Fig. 4b (Bhumkar & Pokharkar, 2006; Xu & Du, 2003). Moreover, FTIR 252 
confirmed the incorporation of KO in CSNPS (Fig. 4 c-g) by comparing with characteristic 253 
peaks in the KO spectra. The occurrence of characteristic peak at same wave number in KO 254 
loaded CSNPs indicating no interaction with chitosan. Similarly, non-interaction behaviour of 255 
chitosan (hydrophilic) with oregano oil (hydrophobic) has earlier been reported by Hosseini et al 256 
when incorporated in CS-TTP nanoparticles (Hosseini et al., 2013). Further, this interaction was 257 
investigated using contact angle measurement and also showed no interaction between KO and 258 
CSNPs as shown in Figure Fig. 5. The contact angle of KO and CSNPs with air was 38.35 and 259 
25.84, respectively as shown in Fig. 5a & b.  However, in case of increasing ratios of KO in 260 
loaded CSNPs the contact angle increased (26.28 – 36.46) that suggests increased 261 
hydrophobicity of KO (Fig. 5 c–g). On the other hand, with maximum KO loaded CSNPs (1:1 & 262 
1: 1.25) showed significant increase in contact angle (10 degree rise). Whereas, at lower ratios 263 
(1: 0.25 – 1: 0.75) of KO loaded CSNPs the contact angle was quite same (26.28 & 31.21) as 264 
appeared in KO with unloaded CSNPs (Fig. c,d). The possible reason behind this increase in 265 
contact angle at highest CS:KO mass ratios is the exposure of excessive oil to standard drop of 266 
KO (3 ul) used during this experimental procedure that resulted in increased hydrophobicity. 267 
These findings revealed that CS and CSNPs showed no interaction with KO. Contact angle 268 
measurement has already been used by variety of researchers to explain the interaction behaviour 269 
of hydrophobic and hydrophilic compounds (Liu et al., 2016; Shamsijazeyi et al., 2014).  270 
On the other hand, the increase in CH stretching peak intensity at 2869 – 2974 cm-1 reflects 271 
the location of KO in the CS matrix. These results were further strengthened as the increase in 272 
CH stretching peak intensity was observed with increasing KO content. Therefore, we can 273 
consider CH stretching as a strong indicator of KO encapsulation in any matrix (Vongsvivut et 274 
al., 2012; Zhao, Wei, Liu, & Liu, 2014). Thus, emulsion and later electrostatic interaction of CS 275 
with TPP, a two-step process successfully encapsulated KO in CSNPs. (Section 3.3) 276 
TGA has been used widely by a variety of researchers to confirm the weight change of 277 
material that is monitored as a function of temperature to evaluate its thermal stability (Yoksan et 278 
al., 2010). In our case, the degree of weight loss for CS alone and KO loaded CSNPs decreased 279 
with increasing temperature from 25 to 600 
o
C as shown in Fig. 6A. KO degradation showed one 280 
level of weight loss Fig. 6A (a). Whereas, CS and KO loaded CSNPs showed two (Fig. 6A-b) 281 
and three levels of weight loss Fig. 6A (c-g). Nam et al. reported the first and second level of 282 
weight loss for CS nanofibers that showed temperature ranges from 56 to 115 
o
C and 182 – 310 283 
o
C, which corresponded to evaporation of moisture and decomposition of polymer, respectively 284 
(Nam, Park, Ihm, & Hudson, 2010). The rate of maximum weight loss corresponding to 285 
temperature was determined as the decomposition temperature (Td), which is clearly observed as 286 
a peak in the derivative thermogravimetry (DTG) thermogram, plotted in Fig. 6B. From the DTG 287 
thermogram, CSNPs exhibited one level Td at 247 
o
C (Fig. 6B-b). By comparison between CS 288 
and KO-loaded CSNPs manifested new Td range 327 – 331 
o
C (Fig. 6B (c-g), which 289 
corresponded to the Td of KO (Fig. 6B-a). The results confirmed the successful loading of KO 290 
into CSNPs. Similarly, Yoksan et al. reported increased thermal stability of successfully 291 
encapsulated ascorbyl palmitate in CSNPs (Yoksan et al., 2010). The weight loss percentage at 292 
this temperature range was thus used to compute the quantity of loaded KO (section 3.3)  293 
XRD patterns of CS powder, CSNPs, and KO-loaded CSNPs are presented in Fig. 7. 294 
Generally, CS exhibits two peaks at 2θ of 10o and 20o (Fig. 7a), showing high degree of 295 
crystallinity. After electrostatic interaction with TPP, peak broadening and peak shifts were 296 
observed with reduction of peak intensity (Fig. 7b). In addition, a new peak is found in the 297 
diffractogram of CSNPs at 2θ of 23o. These distinct differences reflect the modification in the 298 
arrangement of molecules in the crystal lattice stimulated by ionic interaction (Bhumkar & 299 
Pokharkar, 2006; Yoksan et al., 2010). As compared with CSNPs, in the diffraction spectrum of 300 
KO-loaded CSNPs the characteristic peaks at 2θ of 18o confirmed the presence of KO within 301 
CSNPs. Thus, XRD analysis revealed the successful encapsulation of KO in CSNPs as it clearly 302 
showed change in the CS-TPP packing structure. So, on behalf of FTIR, TGA, and XRD we can 303 
conclude that two steps, emulsion and electrostatic interaction between CS and TPP is suitable 304 
for the encapsulation of KO in CSNPs. 305 
3.3 Encapsulation efficiency and loading capacity 306 
The TGA/DTG technique was applied for quantitative analysis of CSNPs in terms of weight 307 
loss at temperature ranging from 290 – 380 oC, corresponding to Td of KO. The percentage of LC 308 
and EE of KO-loaded CSNPs were then calculated using Eqs. (1) and (2), respectively, and are 309 
tabulated in Table 1. From TGA results, the percentage of LC was in the range of 8.8 to 24.7 % 310 
at 25 to 125 % (w/w) ratio of KO to CS (Table 1). LC percentage was dependent on initial KO 311 
content that was in agreement to the findings of  other researchers who reported carvacrol or 312 
BSA loading in CSNPs was initial concentration dependent (Keawchaoon & Yoksan, 2011; Xu 313 
& Du, 2003). EE of KO ranged from 33.3 to 58.9 %. Maximum EE value (58.9 %) was achieved 314 
at 1:0.25 (w/w) CS to KO ratio. However, with the increase of KO ratio, EE started to decrease 315 
as shown in Table 1. This might be due to saturation of CSNPs with KO (Hosseini et al., 2013; 316 
Yoksan et al., 2010), as it possesses a large proportion of marine phospholipids bonded with LC-317 
PUFA and astaxanthin. No doubt, large proportion of phospholipids (about 50 %) in KO bounds 318 
with DHA, EPA and astaxanthin, which enhanced the solubility of these constituents in lipid 319 
phase that consequently reduced its diffusion outside the nanoparticles (Zhu et al., 2015). The 320 
reduction in EE with increasing KO content suggests its loading in CSNPs is limited. 321 
In addition to EE, LC was determined by FTIR using the CH stretching peak to determine 322 
the content of KO in CSNPs. The CH stretching peak at 2925 cm
-1
 and the pyranose peak at 891 323 
cm
-1
 were used as representative peaks of KO and CS, respectively. The CH stretching to 324 
pyranose peak (I2925/I891) is shown in Table 1. CSNPs showed an I2925/I891 value of 0.91 and for 325 
KO-loaded CSNPs, the value of I2925/I891 was greater than 0.91 suggesting successful loading of 326 
KO in the nanoparticles. KO-loaded CSNPs with initial KO content (0.25 – 1.25 g/g) of CS 327 
showed I2925/I891 values in the range of 1.14 – 1.81. The value of I2925/I891 increased with 328 
increasing initial KO content. However, KO-loaded CSNPs with an initial KO content of 1 g/g of 329 
CS provided the maximum value of I2925/I891 as shown in Table 1. These results confirmed the 330 
findings of TGA and we can conclude that the optimal weight ratio of CS to KO was 1:1.  331 
3.4 Oxidative stability 332 
      The oxidative stability of bulk KO and KO containing CSNPs was evaluated using FTIR 333 
spectra that were determined after exposure with elevated oxidative stress (45 
o
C). FTIR 334 
spectroscopy has been used earlier to identify change in the functional groups of the sample that 335 
undergoes lipid oxidation (Voort, Ismail, Sedman, & Emo, 1994). Fig. 8 illustrates obvious 336 
spectral changes in krill oil spectra as oxidation proceeds. However, peak shift in the ROOH 337 
region from ~3416 cm
-1
 to ~3377 suggests the formation of hydroperoxides (Fig. 8-A).  Whereas 338 
change in CO (initial absorption at ~1091 & ~1077 cm
-1
 and gradual shifting to ~1093 & ~1065 339 
cm
-1 
respectively) and trans region confirmed the formation of conjugated trans species (~971 340 
cm-1) along with isolated trans absorptions (~969 cm
-1
) as presented in (Fig. 8-B). In the case of 341 
KO containing CSNPS the ROOH peak shift varied with CS-KO weight ratios. For 1:1, it was 342 
moved to ~3431 to ~3404 cm
-1
 and ~3424 to ~3389 cm
-1
 at 1:1.25 ratio (Fig. 8-C). On the other 343 
hand, the triglyceride ester group peak shifts showed less dependency to CS-KO weight ratios 344 
and it was from ~1741 to ~1739 cm
-1
 at 1:1 & 1:1.25 CS-KO weight ratios as shown in Fig. 8-D. 345 
      The occurrence of a larger shift ~39 cm
-1 
(~3416 – ~3377 cm-1) in the ROOH band under 346 
oxidative stress as shown in Fig. 8 has already been confirmed (Voort et al., 1994). Moreover, 347 
there was a shift back to higher wavenumbers (~3425) that might be due to breakdown of 348 
hydroperoxides to alcohols as evident by the findings of Gullién & Cabo and Voort et al. 349 
(Guillén & Cabo, 1999; Voort et al., 1994). In contrast a band shift of ~12 cm
-1
 of CO groups in 350 
the esters and only a slight (1 – 2 cm-1) shift in cis, conjugated trans, and isolated trans bands 351 
occurred. The KO showed an obvious decrease in the ROOH band and triglyceride ester groups 352 
during the first week of storage. KO-loaded CSNPs showed a modest decrease in band shifts 353 
even after two weeks of storage that suggests more oxidation prevention of KO in CSNPS.  354 
      The oxidation prevention of KO in KO-loaded CSNPs in terms of little change in band shift 355 
of ROOH and triglyceride ester groups under oxidative stress showed less availability of 356 
hydroperoxides to convert them back to aldehydes and ketones (Guillén & Cabo, 2002). Similary 357 
Gullién and Cabo also reported a shift of the ROOH band towards lower wavenumbers as oils 358 
underwent oxidation, but to a somewhat lesser extent (Guillén & Cabo, 1999). Thus, it may be 359 
postulated that the ROOH band shift is due to extensive intermolecular hydrogen bonding of 360 
hydroperoxides (Russin, van de Voort, & Sedman, 2003).  361 
4 Conclusion 362 
The KO loaded CSNPs were prepared by a two-step, emulsion and later electrostatic 363 
interaction of CS with TPP showed average diameter of 80 – 130 nm as observed by SEM. The 364 
loading capacity (LC) and encapsulation efficiency (EE) of KO in nanoparticles was about 8.8 to 365 
24.7 % and 33.3 to 58.9 %, respectively, when the ratio of KO to CS was 25 – 125 %. Moreover, 366 
the loading of KO into CSNPs was confirmed by the increment of CH stretching peak intensity 367 
at 2869 – 2974 cm-1 (FTIR technique), a degradation temperature of 327 – 331 oC (TGA/DTG 368 
techniques), and the characteristic peaks at 2θ of 18o (XRD technique). Further, CSNPS were 369 
successful in preventing the oxidation of KO. The results confirmed the suitability of the 370 
emulsion and electrostatic interaction based method for the formation of KO loaded CSNPs with 371 
greater EE & LC that will enhance their usage in food and pharmaceutical industry. But, prior to 372 
their industrial usage further research is needed on the sensory perception, bioavailability and 373 
protection of encapsulate deterioration during product shelf life.   374 
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Highlights: 506 
 507 
 KO loaded CSNPs were prepared using emulsion-electrostatic interaction method. 508 
 KO loaded CSNPs were irregular in shape with average diameter of < 130 nm. 509 
 CSNPs successfully entrap KO as evident by FTIR. 510 
 KO loaded CSNPs prevented formation of hydroperoxides at elevated temperature. 511 
 512 
 513 
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 515 
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 517 
  518 
Table 1. Loading capacity (LC) and Encapsulation Efficiency (EE) of KO determined by TGA 519 
technique, intensity ration of I2925/890 determined by FTIR technique, and z-average diameter and 520 
ζ-potential value of CS and KO-loaded CSNPs. 521 
 522 
LC = (weight of loaded KO/weight of sample) × 100. 523 
EE = (weight of loaded KO/weight of KO in feed) × 100. 524 
a
 I2925/I890 = Indicates the intensity ration of –CH stretching peak at 2925 cm
-1 
to pyranose peak at  525 
890 cm
-1
. 526 
b
 Indicated values are reported as means ± standard deviation (n = 3) 527 
 528 
  529 
    CS : KO      
(w/w) 
  LC (%)    EE (%) Z-average 
diameter 
b 
ζ-potential      FTIRa  
           
(nm) (mV)    ( I2925/I890) 
1:0.00     0    0 252.0±4.9 37.7±0.0   0.91 
1:0.25     8.8    58.9 229.5±3.9 35.2±0.2   1.14 
1:0.50   13.3    47.1 218.6±0.3 34.3±0.9   1.42 
1:0.75   18.7    41.8 217.6±2.0 31.0±0.5   1.60 
1:1.00   21.8    37.0 191.3±0.2 29.5±0.2   1.81 
1:1.25   24.7    33.3 182.4±1.1 26.6±0.4   1.80 
 530 
 531 
 532 
 533 
 534 
 535 
 536 
 537 
Figure 1. Schematic illustration of KO-loaded CSNPs prepared by emulsion and electrostatic 538 
interaction of CS and TPP. O/W emulsion was stabilized by synergistic effect of two 539 
amphiphiles (i.e., tween 80 and phospholipids inherent in KO) in term of emulsification. A 540 
cartoon of formed KO-loaded CSNPs (inset) indicates the entrapment of oil droplet by 541 
absorption of surfactant molecules with their hydrophilic portions (light blue and dark blue of 542 
phospholipids and tween 80 respectively) oriented toward the aqueous phase and their 543 
hydrophobic portion (black and red of phospholipids and tween 80 respectively) anchored in the 544 
oil. 545 
 546 
 547 
Figure 2. SEM micrographs at 2 kV of (a and b) CSNPs and (c and d) KO-loaded CSNPs 548 
prepared using an initial weight ratio of CS to KO of 1:1.00. 549 
  550 
 551 
 552 
Figure 3. Z-average diameter, PDI and ζ-potential of CSNPs and KO-loaded CSNPs with 553 
different CS to KO weight ratios. Indicated values are the means ± standard deviation (n = 3). 554 
 555 
 556 
 557 
 558 
Figure 4. FTIR spectra of (a) KO, (b) CSNPs and (c)-(g) KO-loaded CSNPs prepared using 559 
different CS to KO weight ratios: (c) 1:0.25, (d) 1:0.50, (e) 1:0.75, (f) 1:1.00, (g) 1:1.25. 560 
 561 
 562 
 563 
Figure 5: The surface contact angle values of (a) KO, (b) CSNPs and (c)-(g) KO-loaded CSNPs 564 
prepared using different CS to KO weight ratios: (c) 1:0.25, (d) 1:0.5, (e) 1:0.75, (f) 1:1, (g) 565 
1:1.25 566 
 567 
 568 
 569 
 570 
 571 
Figure 6. (A) TGA and (B) DTG thermograms of (a) KO, (b) CSNPs and (c)-(g) KO-loaded 572 
CSNPs prepared using different CS to KO weight ratios: (c) 1:0.25, (d) 1:0.50, (e) 1:0.75, (f) 573 
1:1.00, (g) 1:1.25. 574 
 575 
 576 
 577 
 578 
Figure 7. XRD patterns of (a) CS powder, (b) CSNPs and (c) KO-loaded CSNPs. 579 
 580 
 581 
 582 
Figure 8. Time series differential spectra of KO and KO-loaded CSNPs during storage at 45 
o
C/ 583 
4 weeks: (A) ROOH region of KO (~3416 to ~3377 cm
-1
) absorptions, (B) CO region (~1091 to 584 
~1093 cm
-1
 & ~1077 to ~1065 cm
-1
) and trans region of KO (~971 to ~969 cm
-1
) (C) Frequency 585 
values of band near ~3416 cm
-1
 (D) Frequency values of band near ~1741 cm
-1
. 586 
 587 
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